September 20, 2018
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on September 18 announcing that Recordati Rare Diseases has taken over the orphan drug designation for Pola Pharma’s hyperammonemia treatment Carbaglu (carglumic acid). The drug was approved and rolled...read more